nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—germ cell cancer—skin cancer	0.162	0.356	CtDrD
Etoposide—peripheral nervous system neoplasm—skin cancer	0.149	0.328	CtDrD
Etoposide—sarcoma—skin cancer	0.143	0.316	CtDrD
Etoposide—PTGS2—skin cancer	0.111	1	CbGaD
Etoposide—ABCC6—Dactinomycin—skin cancer	0.06	0.183	CbGbCtD
Etoposide—ABCC1—Vemurafenib—skin cancer	0.0266	0.0813	CbGbCtD
Etoposide—ABCC10—Docetaxel—skin cancer	0.0237	0.0723	CbGbCtD
Etoposide—ABCG2—Vismodegib—skin cancer	0.0225	0.0688	CbGbCtD
Etoposide—ABCC3—Fluorouracil—skin cancer	0.0195	0.0595	CbGbCtD
Etoposide—ABCG2—Vemurafenib—skin cancer	0.0178	0.0544	CbGbCtD
Etoposide—ABCC1—Dactinomycin—skin cancer	0.0177	0.054	CbGbCtD
Etoposide—CYP1A2—Imiquimod—skin cancer	0.0134	0.0409	CbGbCtD
Etoposide—CYP2C8—Vismodegib—skin cancer	0.012	0.0367	CbGbCtD
Etoposide—ABCG2—Dactinomycin—skin cancer	0.0118	0.0362	CbGbCtD
Etoposide—CYP2E1—Dacarbazine—skin cancer	0.00973	0.0297	CbGbCtD
Etoposide—ABCC1—Docetaxel—skin cancer	0.00913	0.0279	CbGbCtD
Etoposide—ABCB1—Vismodegib—skin cancer	0.00813	0.0248	CbGbCtD
Etoposide—ABCG2—Fluorouracil—skin cancer	0.008	0.0244	CbGbCtD
Etoposide—CYP1A2—Vemurafenib—skin cancer	0.00735	0.0224	CbGbCtD
Etoposide—CYP3A4—Imiquimod—skin cancer	0.00702	0.0215	CbGbCtD
Etoposide—CYP3A4—Temozolomide—skin cancer	0.00702	0.0215	CbGbCtD
Etoposide—ABCC2—Docetaxel—skin cancer	0.00676	0.0207	CbGbCtD
Etoposide—ABCG2—Docetaxel—skin cancer	0.00611	0.0187	CbGbCtD
Etoposide—CYP1A2—Dacarbazine—skin cancer	0.00563	0.0172	CbGbCtD
Etoposide—CYP3A4—Vismodegib—skin cancer	0.00487	0.0149	CbGbCtD
Etoposide—ABCB1—Dactinomycin—skin cancer	0.00427	0.013	CbGbCtD
Etoposide—CYP2C8—Fluorouracil—skin cancer	0.00426	0.013	CbGbCtD
Etoposide—ABCC6—dermis—skin cancer	0.00396	0.151	CbGeAlD
Etoposide—CYP3A4—Vemurafenib—skin cancer	0.00385	0.0118	CbGbCtD
Etoposide—CYP3A5—Docetaxel—skin cancer	0.00339	0.0103	CbGbCtD
Etoposide—CYP1A2—Fluorouracil—skin cancer	0.0033	0.0101	CbGbCtD
Etoposide—ABCB1—Docetaxel—skin cancer	0.0022	0.00673	CbGbCtD
Etoposide—CYP3A4—Docetaxel—skin cancer	0.00132	0.00403	CbGbCtD
Etoposide—TOP2B—hair follicle—skin cancer	0.00108	0.0412	CbGeAlD
Etoposide—GSTT1—neck—skin cancer	0.000982	0.0375	CbGeAlD
Etoposide—TOP2B—nipple—skin cancer	0.000731	0.0279	CbGeAlD
Etoposide—PTGS2—leg—skin cancer	0.000693	0.0265	CbGeAlD
Etoposide—GSTP1—hair follicle—skin cancer	0.000676	0.0258	CbGeAlD
Etoposide—TOP2A—Sorafenib—Vismodegib—skin cancer	0.000632	0.584	CbGdCrCtD
Etoposide—PTGS2—hindlimb—skin cancer	0.000619	0.0236	CbGeAlD
Etoposide—ABCC6—connective tissue—skin cancer	0.000572	0.0218	CbGeAlD
Etoposide—TOP2A—nipple—skin cancer	0.000538	0.0205	CbGeAlD
Etoposide—PTGS2—appendage—skin cancer	0.000531	0.0203	CbGeAlD
Etoposide—TOP2B—connective tissue—skin cancer	0.000519	0.0198	CbGeAlD
Etoposide—GSTT1—lymphoid tissue—skin cancer	0.000515	0.0197	CbGeAlD
Etoposide—GSTT1—female reproductive system—skin cancer	0.000497	0.019	CbGeAlD
Etoposide—ABCC1—hair follicle—skin cancer	0.000478	0.0182	CbGeAlD
Etoposide—GSTP1—nipple—skin cancer	0.000458	0.0175	CbGeAlD
Etoposide—ABCC10—nipple—skin cancer	0.000458	0.0175	CbGeAlD
Etoposide—GSTP1—neck—skin cancer	0.000453	0.0173	CbGeAlD
Etoposide—TOP2A—Paclitaxel—Docetaxel—skin cancer	0.000451	0.416	CbGdCrCtD
Etoposide—PTGS2—skin epidermis—skin cancer	0.000442	0.0169	CbGeAlD
Etoposide—TOP2B—mammalian vulva—skin cancer	0.000427	0.0163	CbGeAlD
Etoposide—GSTT1—head—skin cancer	0.000415	0.0158	CbGeAlD
Etoposide—TOP2B—lymphoid tissue—skin cancer	0.000379	0.0145	CbGeAlD
Etoposide—TOP2B—female reproductive system—skin cancer	0.000366	0.014	CbGeAlD
Etoposide—ABCC6—head—skin cancer	0.000337	0.0129	CbGeAlD
Etoposide—PTGS1—endothelium—skin cancer	0.000335	0.0128	CbGeAlD
Etoposide—GSTP1—connective tissue—skin cancer	0.000325	0.0124	CbGeAlD
Etoposide—ABCC1—nipple—skin cancer	0.000324	0.0124	CbGeAlD
Etoposide—PTGS2—endothelium—skin cancer	0.000321	0.0122	CbGeAlD
Etoposide—TOP2A—mammalian vulva—skin cancer	0.000314	0.012	CbGeAlD
Etoposide—PTGS1—blood vessel—skin cancer	0.000309	0.0118	CbGeAlD
Etoposide—GSTP1—epithelium—skin cancer	0.000308	0.0118	CbGeAlD
Etoposide—TOP2B—head—skin cancer	0.000306	0.0117	CbGeAlD
Etoposide—PTGS2—blood vessel—skin cancer	0.000296	0.0113	CbGeAlD
Etoposide—GSTP1—skin of body—skin cancer	0.000293	0.0112	CbGeAlD
Etoposide—GSTP1—mammalian vulva—skin cancer	0.000268	0.0102	CbGeAlD
Etoposide—ABCC10—mammalian vulva—skin cancer	0.000267	0.0102	CbGeAlD
Etoposide—CYP1A2—nipple—skin cancer	0.000258	0.00985	CbGeAlD
Etoposide—GSTP1—lymphoid tissue—skin cancer	0.000238	0.00907	CbGeAlD
Etoposide—ABCC10—lymphoid tissue—skin cancer	0.000237	0.00906	CbGeAlD
Etoposide—ABCC3—female reproductive system—skin cancer	0.00023	0.00878	CbGeAlD
Etoposide—GSTP1—female reproductive system—skin cancer	0.000229	0.00875	CbGeAlD
Etoposide—ABCC10—female reproductive system—skin cancer	0.000229	0.00874	CbGeAlD
Etoposide—PTGS1—nipple—skin cancer	0.000224	0.00853	CbGeAlD
Etoposide—TOP2B—lymph node—skin cancer	0.000214	0.00817	CbGeAlD
Etoposide—ABCC3—head—skin cancer	0.000192	0.00734	CbGeAlD
Etoposide—GSTP1—head—skin cancer	0.000191	0.00731	CbGeAlD
Etoposide—ABCC1—mammalian vulva—skin cancer	0.000189	0.00722	CbGeAlD
Etoposide—ABCC2—female reproductive system—skin cancer	0.000184	0.00702	CbGeAlD
Etoposide—ABCB1—blood vessel—skin cancer	0.000183	0.00698	CbGeAlD
Etoposide—PTGS1—connective tissue—skin cancer	0.000159	0.00605	CbGeAlD
Etoposide—TOP2A—lymph node—skin cancer	0.000157	0.00601	CbGeAlD
Etoposide—ABCG2—mammalian vulva—skin cancer	0.000157	0.00598	CbGeAlD
Etoposide—PTGS2—connective tissue—skin cancer	0.000152	0.00579	CbGeAlD
Etoposide—PTGS1—epithelium—skin cancer	0.000151	0.00575	CbGeAlD
Etoposide—PTGS2—epithelium—skin cancer	0.000144	0.00549	CbGeAlD
Etoposide—PTGS1—skin of body—skin cancer	0.000143	0.00547	CbGeAlD
Etoposide—CYP2C8—female reproductive system—skin cancer	0.000138	0.00526	CbGeAlD
Etoposide—PTGS2—skin of body—skin cancer	0.000137	0.00522	CbGeAlD
Etoposide—ABCC3—lymph node—skin cancer	0.000135	0.00514	CbGeAlD
Etoposide—GSTP1—lymph node—skin cancer	0.000134	0.00512	CbGeAlD
Etoposide—ABCC10—lymph node—skin cancer	0.000134	0.00511	CbGeAlD
Etoposide—PTGS1—mammalian vulva—skin cancer	0.000131	0.00498	CbGeAlD
Etoposide—CYP2E1—lymphoid tissue—skin cancer	0.00012	0.00459	CbGeAlD
Etoposide—CYP2E1—female reproductive system—skin cancer	0.000116	0.00443	CbGeAlD
Etoposide—PTGS1—female reproductive system—skin cancer	0.000112	0.00427	CbGeAlD
Etoposide—Hepatobiliary disease—Temozolomide—skin cancer	0.000112	0.00139	CcSEcCtD
Etoposide—Alopecia—Bleomycin—skin cancer	0.000111	0.00138	CcSEcCtD
Etoposide—PTGS2—lymphoid tissue—skin cancer	0.000111	0.00423	CbGeAlD
Etoposide—Erythema multiforme—Dactinomycin—skin cancer	0.000111	0.00138	CcSEcCtD
Etoposide—Pneumonia—Fluorouracil—skin cancer	0.000109	0.00136	CcSEcCtD
Etoposide—Decreased appetite—Imiquimod—skin cancer	0.000109	0.00136	CcSEcCtD
Etoposide—Infestation—Fluorouracil—skin cancer	0.000109	0.00135	CcSEcCtD
Etoposide—Infestation NOS—Fluorouracil—skin cancer	0.000109	0.00135	CcSEcCtD
Etoposide—Flushing—Dactinomycin—skin cancer	0.000109	0.00135	CcSEcCtD
Etoposide—Hypersensitivity—Vemurafenib—skin cancer	0.000108	0.00135	CcSEcCtD
Etoposide—Gastrointestinal disorder—Imiquimod—skin cancer	0.000108	0.00135	CcSEcCtD
Etoposide—Fatigue—Imiquimod—skin cancer	0.000108	0.00135	CcSEcCtD
Etoposide—ABCC2—lymph node—skin cancer	0.000108	0.00411	CbGeAlD
Etoposide—Pain—Imiquimod—skin cancer	0.000107	0.00134	CcSEcCtD
Etoposide—Acute coronary syndrome—Fluorouracil—skin cancer	0.000107	0.00133	CcSEcCtD
Etoposide—PTGS2—female reproductive system—skin cancer	0.000107	0.00408	CbGeAlD
Etoposide—Neuropathy peripheral—Fluorouracil—skin cancer	0.000106	0.00133	CcSEcCtD
Etoposide—Myocardial infarction—Fluorouracil—skin cancer	0.000106	0.00133	CcSEcCtD
Etoposide—Stomatitis—Fluorouracil—skin cancer	0.000106	0.00132	CcSEcCtD
Etoposide—Asthenia—Vemurafenib—skin cancer	0.000106	0.00131	CcSEcCtD
Etoposide—Hypoaesthesia—Temozolomide—skin cancer	0.000105	0.00131	CcSEcCtD
Etoposide—Chills—Dactinomycin—skin cancer	0.000105	0.00131	CcSEcCtD
Etoposide—Urinary tract disorder—Temozolomide—skin cancer	0.000105	0.0013	CcSEcCtD
Etoposide—Cardiac failure—Docetaxel—skin cancer	0.000104	0.0013	CcSEcCtD
Etoposide—Pruritus—Vemurafenib—skin cancer	0.000104	0.0013	CcSEcCtD
Etoposide—Urethral disorder—Temozolomide—skin cancer	0.000104	0.00129	CcSEcCtD
Etoposide—Alopecia—Dactinomycin—skin cancer	0.000103	0.00129	CcSEcCtD
Etoposide—Feeling abnormal—Imiquimod—skin cancer	0.000103	0.00129	CcSEcCtD
Etoposide—Gastrointestinal pain—Imiquimod—skin cancer	0.000103	0.00128	CcSEcCtD
Etoposide—Agranulocytosis—Fluorouracil—skin cancer	0.000101	0.00126	CcSEcCtD
Etoposide—Ill-defined disorder—Bleomycin—skin cancer	0.000101	0.00126	CcSEcCtD
Etoposide—Anaemia—Bleomycin—skin cancer	0.000101	0.00126	CcSEcCtD
Etoposide—Diarrhoea—Vemurafenib—skin cancer	0.000101	0.00125	CcSEcCtD
Etoposide—Erythema multiforme—Temozolomide—skin cancer	0.0001	0.00125	CcSEcCtD
Etoposide—Urticaria—Imiquimod—skin cancer	9.97e-05	0.00124	CcSEcCtD
Etoposide—Body temperature increased—Imiquimod—skin cancer	9.92e-05	0.00124	CcSEcCtD
Etoposide—Abdominal pain—Imiquimod—skin cancer	9.92e-05	0.00124	CcSEcCtD
Etoposide—Eye disorder—Temozolomide—skin cancer	9.89e-05	0.00123	CcSEcCtD
Etoposide—Malaise—Bleomycin—skin cancer	9.85e-05	0.00123	CcSEcCtD
Etoposide—Cardiac disorder—Temozolomide—skin cancer	9.82e-05	0.00122	CcSEcCtD
Etoposide—Flushing—Temozolomide—skin cancer	9.82e-05	0.00122	CcSEcCtD
Etoposide—Leukopenia—Bleomycin—skin cancer	9.78e-05	0.00122	CcSEcCtD
Etoposide—Dizziness—Vemurafenib—skin cancer	9.73e-05	0.00121	CcSEcCtD
Etoposide—Hypoaesthesia—Fluorouracil—skin cancer	9.7e-05	0.00121	CcSEcCtD
Etoposide—CYP2E1—head—skin cancer	9.7e-05	0.0037	CbGeAlD
Etoposide—Angiopathy—Temozolomide—skin cancer	9.6e-05	0.0012	CcSEcCtD
Etoposide—Immune system disorder—Temozolomide—skin cancer	9.56e-05	0.00119	CcSEcCtD
Etoposide—Mediastinal disorder—Temozolomide—skin cancer	9.54e-05	0.00119	CcSEcCtD
Etoposide—Cough—Bleomycin—skin cancer	9.53e-05	0.00119	CcSEcCtD
Etoposide—Chills—Temozolomide—skin cancer	9.5e-05	0.00118	CcSEcCtD
Etoposide—ABCC1—lymph node—skin cancer	9.47e-05	0.00362	CbGeAlD
Etoposide—Ill-defined disorder—Dactinomycin—skin cancer	9.45e-05	0.00118	CcSEcCtD
Etoposide—Anaemia—Dactinomycin—skin cancer	9.42e-05	0.00117	CcSEcCtD
Etoposide—Vomiting—Vemurafenib—skin cancer	9.36e-05	0.00117	CcSEcCtD
Etoposide—Alopecia—Temozolomide—skin cancer	9.35e-05	0.00116	CcSEcCtD
Etoposide—PTGS1—head—skin cancer	9.34e-05	0.00357	CbGeAlD
Etoposide—CYP3A4—female reproductive system—skin cancer	9.34e-05	0.00357	CbGeAlD
Etoposide—Chest pain—Bleomycin—skin cancer	9.3e-05	0.00116	CcSEcCtD
Etoposide—Rash—Vemurafenib—skin cancer	9.28e-05	0.00116	CcSEcCtD
Etoposide—Dermatitis—Vemurafenib—skin cancer	9.27e-05	0.00115	CcSEcCtD
Etoposide—Hypersensitivity—Imiquimod—skin cancer	9.24e-05	0.00115	CcSEcCtD
Etoposide—Headache—Vemurafenib—skin cancer	9.22e-05	0.00115	CcSEcCtD
Etoposide—Discomfort—Bleomycin—skin cancer	9.19e-05	0.00114	CcSEcCtD
Etoposide—Malaise—Dactinomycin—skin cancer	9.19e-05	0.00114	CcSEcCtD
Etoposide—Cramp muscle—Docetaxel—skin cancer	9.16e-05	0.00114	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Docetaxel—skin cancer	9.16e-05	0.00114	CcSEcCtD
Etoposide—Leukopenia—Dactinomycin—skin cancer	9.12e-05	0.00114	CcSEcCtD
Etoposide—Dysgeusia—Temozolomide—skin cancer	9.02e-05	0.00112	CcSEcCtD
Etoposide—Asthenia—Imiquimod—skin cancer	9e-05	0.00112	CcSEcCtD
Etoposide—Confusional state—Bleomycin—skin cancer	8.99e-05	0.00112	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Docetaxel—skin cancer	8.97e-05	0.00112	CcSEcCtD
Etoposide—PTGS2—head—skin cancer	8.93e-05	0.00341	CbGeAlD
Etoposide—Anaphylactic shock—Bleomycin—skin cancer	8.91e-05	0.00111	CcSEcCtD
Etoposide—Back pain—Temozolomide—skin cancer	8.91e-05	0.00111	CcSEcCtD
Etoposide—ABCB1—epithelium—skin cancer	8.9e-05	0.0034	CbGeAlD
Etoposide—Pruritus—Imiquimod—skin cancer	8.88e-05	0.00111	CcSEcCtD
Etoposide—Infection—Bleomycin—skin cancer	8.86e-05	0.0011	CcSEcCtD
Etoposide—Dysphagia—Docetaxel—skin cancer	8.79e-05	0.0011	CcSEcCtD
Etoposide—Nausea—Vemurafenib—skin cancer	8.74e-05	0.00109	CcSEcCtD
Etoposide—Thrombocytopenia—Bleomycin—skin cancer	8.73e-05	0.00109	CcSEcCtD
Etoposide—Bronchospasm—Docetaxel—skin cancer	8.65e-05	0.00108	CcSEcCtD
Etoposide—Alopecia—Fluorouracil—skin cancer	8.62e-05	0.00107	CcSEcCtD
Etoposide—Diarrhoea—Imiquimod—skin cancer	8.59e-05	0.00107	CcSEcCtD
Etoposide—Discomfort—Dactinomycin—skin cancer	8.57e-05	0.00107	CcSEcCtD
Etoposide—Ill-defined disorder—Temozolomide—skin cancer	8.55e-05	0.00106	CcSEcCtD
Etoposide—Anaemia—Temozolomide—skin cancer	8.52e-05	0.00106	CcSEcCtD
Etoposide—Anorexia—Bleomycin—skin cancer	8.5e-05	0.00106	CcSEcCtD
Etoposide—Pancytopenia—Docetaxel—skin cancer	8.35e-05	0.00104	CcSEcCtD
Etoposide—Hypotension—Bleomycin—skin cancer	8.33e-05	0.00104	CcSEcCtD
Etoposide—Malaise—Temozolomide—skin cancer	8.31e-05	0.00103	CcSEcCtD
Etoposide—Dizziness—Imiquimod—skin cancer	8.3e-05	0.00103	CcSEcCtD
Etoposide—Vertigo—Temozolomide—skin cancer	8.28e-05	0.00103	CcSEcCtD
Etoposide—Infection—Dactinomycin—skin cancer	8.26e-05	0.00103	CcSEcCtD
Etoposide—Leukopenia—Temozolomide—skin cancer	8.25e-05	0.00103	CcSEcCtD
Etoposide—Neutropenia—Docetaxel—skin cancer	8.22e-05	0.00102	CcSEcCtD
Etoposide—Thrombocytopenia—Dactinomycin—skin cancer	8.14e-05	0.00101	CcSEcCtD
Etoposide—Cough—Temozolomide—skin cancer	8.04e-05	0.001	CcSEcCtD
Etoposide—Paraesthesia—Bleomycin—skin cancer	8e-05	0.000997	CcSEcCtD
Etoposide—Convulsion—Temozolomide—skin cancer	7.98e-05	0.000994	CcSEcCtD
Etoposide—Vomiting—Imiquimod—skin cancer	7.98e-05	0.000994	CcSEcCtD
Etoposide—Hypertension—Temozolomide—skin cancer	7.95e-05	0.000991	CcSEcCtD
Etoposide—Dyspnoea—Bleomycin—skin cancer	7.95e-05	0.00099	CcSEcCtD
Etoposide—Anorexia—Dactinomycin—skin cancer	7.92e-05	0.000987	CcSEcCtD
Etoposide—Rash—Imiquimod—skin cancer	7.91e-05	0.000985	CcSEcCtD
Etoposide—Dermatitis—Imiquimod—skin cancer	7.9e-05	0.000985	CcSEcCtD
Etoposide—Pneumonia—Docetaxel—skin cancer	7.89e-05	0.000982	CcSEcCtD
Etoposide—Headache—Imiquimod—skin cancer	7.86e-05	0.000979	CcSEcCtD
Etoposide—Anaemia—Fluorouracil—skin cancer	7.85e-05	0.000977	CcSEcCtD
Etoposide—ABCG2—lymph node—skin cancer	7.84e-05	0.00299	CbGeAlD
Etoposide—Infestation NOS—Docetaxel—skin cancer	7.84e-05	0.000977	CcSEcCtD
Etoposide—Infestation—Docetaxel—skin cancer	7.84e-05	0.000977	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	7.79e-05	0.00097	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Docetaxel—skin cancer	7.77e-05	0.000968	CcSEcCtD
Etoposide—Discomfort—Temozolomide—skin cancer	7.75e-05	0.000965	CcSEcCtD
Etoposide—Decreased appetite—Bleomycin—skin cancer	7.75e-05	0.000965	CcSEcCtD
Etoposide—Acute coronary syndrome—Docetaxel—skin cancer	7.73e-05	0.000963	CcSEcCtD
Etoposide—ABCB1—mammalian vulva—skin cancer	7.72e-05	0.00295	CbGeAlD
Etoposide—Renal failure—Docetaxel—skin cancer	7.71e-05	0.00096	CcSEcCtD
Etoposide—Myocardial infarction—Docetaxel—skin cancer	7.69e-05	0.000957	CcSEcCtD
Etoposide—Neuropathy peripheral—Docetaxel—skin cancer	7.69e-05	0.000957	CcSEcCtD
Etoposide—Jaundice—Docetaxel—skin cancer	7.64e-05	0.000952	CcSEcCtD
Etoposide—Stomatitis—Docetaxel—skin cancer	7.64e-05	0.000952	CcSEcCtD
Etoposide—Pain—Bleomycin—skin cancer	7.62e-05	0.00095	CcSEcCtD
Etoposide—Leukopenia—Fluorouracil—skin cancer	7.6e-05	0.000947	CcSEcCtD
Etoposide—Confusional state—Temozolomide—skin cancer	7.58e-05	0.000944	CcSEcCtD
Etoposide—Anaphylactic shock—Temozolomide—skin cancer	7.52e-05	0.000937	CcSEcCtD
Etoposide—Infection—Temozolomide—skin cancer	7.47e-05	0.000931	CcSEcCtD
Etoposide—Nausea—Imiquimod—skin cancer	7.45e-05	0.000928	CcSEcCtD
Etoposide—Hepatobiliary disease—Docetaxel—skin cancer	7.42e-05	0.000924	CcSEcCtD
Etoposide—Thrombocytopenia—Temozolomide—skin cancer	7.36e-05	0.000917	CcSEcCtD
Etoposide—Convulsion—Fluorouracil—skin cancer	7.36e-05	0.000916	CcSEcCtD
Etoposide—Feeling abnormal—Bleomycin—skin cancer	7.35e-05	0.000915	CcSEcCtD
Etoposide—Agranulocytosis—Docetaxel—skin cancer	7.32e-05	0.000911	CcSEcCtD
Etoposide—Skin disorder—Temozolomide—skin cancer	7.3e-05	0.00091	CcSEcCtD
Etoposide—Hyperhidrosis—Temozolomide—skin cancer	7.27e-05	0.000905	CcSEcCtD
Etoposide—Chest pain—Fluorouracil—skin cancer	7.23e-05	0.0009	CcSEcCtD
Etoposide—Decreased appetite—Dactinomycin—skin cancer	7.23e-05	0.0009	CcSEcCtD
Etoposide—Fatigue—Dactinomycin—skin cancer	7.17e-05	0.000893	CcSEcCtD
Etoposide—Anorexia—Temozolomide—skin cancer	7.17e-05	0.000893	CcSEcCtD
Etoposide—Discomfort—Fluorouracil—skin cancer	7.14e-05	0.000889	CcSEcCtD
Etoposide—Pain—Dactinomycin—skin cancer	7.11e-05	0.000886	CcSEcCtD
Etoposide—Urticaria—Bleomycin—skin cancer	7.08e-05	0.000882	CcSEcCtD
Etoposide—Body temperature increased—Bleomycin—skin cancer	7.05e-05	0.000878	CcSEcCtD
Etoposide—Hypoaesthesia—Docetaxel—skin cancer	7e-05	0.000872	CcSEcCtD
Etoposide—Confusional state—Fluorouracil—skin cancer	6.99e-05	0.00087	CcSEcCtD
Etoposide—Urinary tract disorder—Docetaxel—skin cancer	6.95e-05	0.000866	CcSEcCtD
Etoposide—Anaphylactic shock—Fluorouracil—skin cancer	6.93e-05	0.000863	CcSEcCtD
Etoposide—Urethral disorder—Docetaxel—skin cancer	6.9e-05	0.000859	CcSEcCtD
Etoposide—Infection—Fluorouracil—skin cancer	6.88e-05	0.000857	CcSEcCtD
Etoposide—ABCB1—lymphoid tissue—skin cancer	6.85e-05	0.00262	CbGeAlD
Etoposide—Feeling abnormal—Dactinomycin—skin cancer	6.85e-05	0.000853	CcSEcCtD
Etoposide—Gastrointestinal pain—Dactinomycin—skin cancer	6.8e-05	0.000847	CcSEcCtD
Etoposide—Thrombocytopenia—Fluorouracil—skin cancer	6.78e-05	0.000845	CcSEcCtD
Etoposide—Tachycardia—Fluorouracil—skin cancer	6.76e-05	0.000842	CcSEcCtD
Etoposide—Paraesthesia—Temozolomide—skin cancer	6.75e-05	0.000841	CcSEcCtD
Etoposide—Dyspnoea—Temozolomide—skin cancer	6.7e-05	0.000835	CcSEcCtD
Etoposide—Somnolence—Temozolomide—skin cancer	6.69e-05	0.000833	CcSEcCtD
Etoposide—Erythema multiforme—Docetaxel—skin cancer	6.66e-05	0.000829	CcSEcCtD
Etoposide—ABCB1—female reproductive system—skin cancer	6.61e-05	0.00252	CbGeAlD
Etoposide—Anorexia—Fluorouracil—skin cancer	6.6e-05	0.000823	CcSEcCtD
Etoposide—Eye disorder—Docetaxel—skin cancer	6.58e-05	0.000819	CcSEcCtD
Etoposide—Abdominal pain—Dactinomycin—skin cancer	6.57e-05	0.000819	CcSEcCtD
Etoposide—Body temperature increased—Dactinomycin—skin cancer	6.57e-05	0.000819	CcSEcCtD
Etoposide—Hypersensitivity—Bleomycin—skin cancer	6.57e-05	0.000818	CcSEcCtD
Etoposide—PTGS1—lymph node—skin cancer	6.54e-05	0.0025	CbGeAlD
Etoposide—Decreased appetite—Temozolomide—skin cancer	6.54e-05	0.000814	CcSEcCtD
Etoposide—Cardiac disorder—Docetaxel—skin cancer	6.53e-05	0.000814	CcSEcCtD
Etoposide—Flushing—Docetaxel—skin cancer	6.53e-05	0.000814	CcSEcCtD
Etoposide—Gastrointestinal disorder—Temozolomide—skin cancer	6.49e-05	0.000809	CcSEcCtD
Etoposide—Fatigue—Temozolomide—skin cancer	6.48e-05	0.000808	CcSEcCtD
Etoposide—Hypotension—Fluorouracil—skin cancer	6.47e-05	0.000806	CcSEcCtD
Etoposide—Constipation—Temozolomide—skin cancer	6.43e-05	0.000801	CcSEcCtD
Etoposide—Pain—Temozolomide—skin cancer	6.43e-05	0.000801	CcSEcCtD
Etoposide—Asthenia—Bleomycin—skin cancer	6.4e-05	0.000797	CcSEcCtD
Etoposide—Angiopathy—Docetaxel—skin cancer	6.39e-05	0.000795	CcSEcCtD
Etoposide—Immune system disorder—Docetaxel—skin cancer	6.36e-05	0.000792	CcSEcCtD
Etoposide—Mediastinal disorder—Docetaxel—skin cancer	6.34e-05	0.00079	CcSEcCtD
Etoposide—Chills—Docetaxel—skin cancer	6.32e-05	0.000787	CcSEcCtD
Etoposide—Pruritus—Bleomycin—skin cancer	6.31e-05	0.000786	CcSEcCtD
Etoposide—PTGS2—lymph node—skin cancer	6.25e-05	0.00239	CbGeAlD
Etoposide—Paraesthesia—Fluorouracil—skin cancer	6.22e-05	0.000775	CcSEcCtD
Etoposide—Alopecia—Docetaxel—skin cancer	6.22e-05	0.000775	CcSEcCtD
Etoposide—Feeling abnormal—Temozolomide—skin cancer	6.2e-05	0.000772	CcSEcCtD
Etoposide—Dyspnoea—Fluorouracil—skin cancer	6.18e-05	0.000769	CcSEcCtD
Etoposide—Somnolence—Fluorouracil—skin cancer	6.16e-05	0.000767	CcSEcCtD
Etoposide—Gastrointestinal pain—Temozolomide—skin cancer	6.15e-05	0.000766	CcSEcCtD
Etoposide—Hypersensitivity—Dactinomycin—skin cancer	6.13e-05	0.000763	CcSEcCtD
Etoposide—Decreased appetite—Fluorouracil—skin cancer	6.02e-05	0.00075	CcSEcCtD
Etoposide—Dysgeusia—Docetaxel—skin cancer	6e-05	0.000747	CcSEcCtD
Etoposide—Gastrointestinal disorder—Fluorouracil—skin cancer	5.98e-05	0.000745	CcSEcCtD
Etoposide—Urticaria—Temozolomide—skin cancer	5.97e-05	0.000744	CcSEcCtD
Etoposide—Asthenia—Dactinomycin—skin cancer	5.97e-05	0.000743	CcSEcCtD
Etoposide—Abdominal pain—Temozolomide—skin cancer	5.94e-05	0.00074	CcSEcCtD
Etoposide—Body temperature increased—Temozolomide—skin cancer	5.94e-05	0.00074	CcSEcCtD
Etoposide—Back pain—Docetaxel—skin cancer	5.93e-05	0.000738	CcSEcCtD
Etoposide—Pain—Fluorouracil—skin cancer	5.92e-05	0.000738	CcSEcCtD
Etoposide—Muscle spasms—Docetaxel—skin cancer	5.89e-05	0.000734	CcSEcCtD
Etoposide—Feeling abnormal—Fluorouracil—skin cancer	5.71e-05	0.000711	CcSEcCtD
Etoposide—Diarrhoea—Dactinomycin—skin cancer	5.69e-05	0.000709	CcSEcCtD
Etoposide—Vomiting—Bleomycin—skin cancer	5.67e-05	0.000706	CcSEcCtD
Etoposide—Anaemia—Docetaxel—skin cancer	5.66e-05	0.000705	CcSEcCtD
Etoposide—Rash—Bleomycin—skin cancer	5.62e-05	0.0007	CcSEcCtD
Etoposide—Dermatitis—Bleomycin—skin cancer	5.62e-05	0.000699	CcSEcCtD
Etoposide—Hypersensitivity—Temozolomide—skin cancer	5.54e-05	0.00069	CcSEcCtD
Etoposide—ABCB1—head—skin cancer	5.52e-05	0.00211	CbGeAlD
Etoposide—Urticaria—Fluorouracil—skin cancer	5.5e-05	0.000686	CcSEcCtD
Etoposide—Leukopenia—Docetaxel—skin cancer	5.48e-05	0.000683	CcSEcCtD
Etoposide—Body temperature increased—Fluorouracil—skin cancer	5.48e-05	0.000682	CcSEcCtD
Etoposide—Asthenia—Temozolomide—skin cancer	5.4e-05	0.000672	CcSEcCtD
Etoposide—Loss of consciousness—Docetaxel—skin cancer	5.39e-05	0.000671	CcSEcCtD
Etoposide—Cough—Docetaxel—skin cancer	5.35e-05	0.000666	CcSEcCtD
Etoposide—Pruritus—Temozolomide—skin cancer	5.32e-05	0.000663	CcSEcCtD
Etoposide—Convulsion—Docetaxel—skin cancer	5.31e-05	0.000661	CcSEcCtD
Etoposide—Nausea—Bleomycin—skin cancer	5.3e-05	0.00066	CcSEcCtD
Etoposide—Hypertension—Docetaxel—skin cancer	5.29e-05	0.000659	CcSEcCtD
Etoposide—Vomiting—Dactinomycin—skin cancer	5.29e-05	0.000658	CcSEcCtD
Etoposide—Rash—Dactinomycin—skin cancer	5.24e-05	0.000653	CcSEcCtD
Etoposide—Chest pain—Docetaxel—skin cancer	5.22e-05	0.00065	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	5.18e-05	0.000645	CcSEcCtD
Etoposide—Diarrhoea—Temozolomide—skin cancer	5.15e-05	0.000641	CcSEcCtD
Etoposide—Hypersensitivity—Fluorouracil—skin cancer	5.1e-05	0.000636	CcSEcCtD
Etoposide—Confusional state—Docetaxel—skin cancer	5.04e-05	0.000628	CcSEcCtD
Etoposide—Anaphylactic shock—Docetaxel—skin cancer	5e-05	0.000623	CcSEcCtD
Etoposide—Dizziness—Temozolomide—skin cancer	4.97e-05	0.000619	CcSEcCtD
Etoposide—Infection—Docetaxel—skin cancer	4.97e-05	0.000619	CcSEcCtD
Etoposide—Nausea—Dactinomycin—skin cancer	4.94e-05	0.000615	CcSEcCtD
Etoposide—Pruritus—Fluorouracil—skin cancer	4.9e-05	0.000611	CcSEcCtD
Etoposide—Thrombocytopenia—Docetaxel—skin cancer	4.9e-05	0.00061	CcSEcCtD
Etoposide—Tachycardia—Docetaxel—skin cancer	4.88e-05	0.000608	CcSEcCtD
Etoposide—Skin disorder—Docetaxel—skin cancer	4.86e-05	0.000605	CcSEcCtD
Etoposide—Vomiting—Temozolomide—skin cancer	4.78e-05	0.000596	CcSEcCtD
Etoposide—Anorexia—Docetaxel—skin cancer	4.77e-05	0.000594	CcSEcCtD
Etoposide—Rash—Temozolomide—skin cancer	4.74e-05	0.000591	CcSEcCtD
Etoposide—Diarrhoea—Fluorouracil—skin cancer	4.74e-05	0.00059	CcSEcCtD
Etoposide—Dermatitis—Temozolomide—skin cancer	4.74e-05	0.00059	CcSEcCtD
Etoposide—Headache—Temozolomide—skin cancer	4.71e-05	0.000587	CcSEcCtD
Etoposide—Hypotension—Docetaxel—skin cancer	4.67e-05	0.000582	CcSEcCtD
Etoposide—Dizziness—Fluorouracil—skin cancer	4.58e-05	0.000571	CcSEcCtD
Etoposide—Paraesthesia—Docetaxel—skin cancer	4.49e-05	0.000559	CcSEcCtD
Etoposide—Nausea—Temozolomide—skin cancer	4.47e-05	0.000556	CcSEcCtD
Etoposide—Dyspnoea—Docetaxel—skin cancer	4.46e-05	0.000555	CcSEcCtD
Etoposide—Somnolence—Docetaxel—skin cancer	4.45e-05	0.000554	CcSEcCtD
Etoposide—Vomiting—Fluorouracil—skin cancer	4.41e-05	0.000549	CcSEcCtD
Etoposide—Rash—Fluorouracil—skin cancer	4.37e-05	0.000544	CcSEcCtD
Etoposide—Dermatitis—Fluorouracil—skin cancer	4.36e-05	0.000544	CcSEcCtD
Etoposide—Decreased appetite—Docetaxel—skin cancer	4.35e-05	0.000541	CcSEcCtD
Etoposide—Headache—Fluorouracil—skin cancer	4.34e-05	0.000541	CcSEcCtD
Etoposide—Gastrointestinal disorder—Docetaxel—skin cancer	4.32e-05	0.000538	CcSEcCtD
Etoposide—Fatigue—Docetaxel—skin cancer	4.31e-05	0.000537	CcSEcCtD
Etoposide—Pain—Docetaxel—skin cancer	4.28e-05	0.000533	CcSEcCtD
Etoposide—Constipation—Docetaxel—skin cancer	4.28e-05	0.000533	CcSEcCtD
Etoposide—Feeling abnormal—Docetaxel—skin cancer	4.12e-05	0.000513	CcSEcCtD
Etoposide—Nausea—Fluorouracil—skin cancer	4.12e-05	0.000513	CcSEcCtD
Etoposide—Gastrointestinal pain—Docetaxel—skin cancer	4.09e-05	0.000509	CcSEcCtD
Etoposide—Body temperature increased—Docetaxel—skin cancer	3.95e-05	0.000492	CcSEcCtD
Etoposide—Abdominal pain—Docetaxel—skin cancer	3.95e-05	0.000492	CcSEcCtD
Etoposide—ABCB1—lymph node—skin cancer	3.87e-05	0.00148	CbGeAlD
Etoposide—Hypersensitivity—Docetaxel—skin cancer	3.68e-05	0.000459	CcSEcCtD
Etoposide—Asthenia—Docetaxel—skin cancer	3.59e-05	0.000447	CcSEcCtD
Etoposide—Pruritus—Docetaxel—skin cancer	3.54e-05	0.000441	CcSEcCtD
Etoposide—Diarrhoea—Docetaxel—skin cancer	3.42e-05	0.000426	CcSEcCtD
Etoposide—Dizziness—Docetaxel—skin cancer	3.31e-05	0.000412	CcSEcCtD
Etoposide—Vomiting—Docetaxel—skin cancer	3.18e-05	0.000396	CcSEcCtD
Etoposide—Rash—Docetaxel—skin cancer	3.15e-05	0.000393	CcSEcCtD
Etoposide—Dermatitis—Docetaxel—skin cancer	3.15e-05	0.000392	CcSEcCtD
Etoposide—Headache—Docetaxel—skin cancer	3.13e-05	0.00039	CcSEcCtD
Etoposide—Nausea—Docetaxel—skin cancer	2.97e-05	0.00037	CcSEcCtD
